Akero - AKRO Choraklik daromad o'sishi

Akero Therapeutics (AKRO) - korporativ logo

Akero Therapeutics (AKRO) barqaror pul oqimlariga ega emas, chunki u mahsulotlari bozorga chiqquncha faqat tashqi kapitalga tayanadi. GURU.Markets grafigida ko'rsatilganidek, kompaniyaning choraklik daromadlari o'sishi 0.00 yangi darajaga yetayotganini ko'rsatmoqda, shu bilan birga, jigarga qarshi dori vositalari sinovlaridagi potentsial muvaffaqiyatsizliklar tufayli biznes kapitalizatsiyaning qulashi xavfi ostida turibdi. Biroq, bir nechta metabolik patologiya tadqiqot dasturlarining diversifikatsiyasi umumiy xatarlarni yumshatadi.

AKRO Akero Therapeutics Inc Choraklik sotuv ortish sur'ati (04.07.2022 - 20.12.2025)

Akero Therapeutics, Inc. (AKRO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- pul mablag'lari va pul oqimlari ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Akero Therapeutics, Inc. (AKRO)
Akero tomonidan chiqariladigan mahsulotlar

Fundamental risk baholash haqiqiy savdo dinamikasini tahlil qilishni talab etadi, bunda choraklik daromad o'sish sur'atlari inflyatsiyaviy shovqinlarni filtrlash va pasayib borayotgan tijorat momentumini aniqlash imkonini beradi. Akero Therapeutics (AKRO) uchun ushbu ko'rsatkich uning AI yechimlari va robotlashtirilgan bioanaliz tizimlariga bo'lgan bozor talabini aks ettiradi hamda ketma-ket davrlardagi daromadning foiz o'zgarishi orqali klinik testlar avtomatlashtirilganligining samaradorligini namoyish etadi.

Asosiy raqobatchilar

ASND - Daromadning choraklik o'sishi (QoQ)|MDGL: Daromadning choraklik o'sishi (QoQ)|CORT: Choraklik daromad o'sishi|RYTM - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) Metsera Therapeutics|MoonLake Corp (MLTX) - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) crinetics.com (CRNX)|Choraklik sotuv o'sishi newamsterdampharma.com NAMS|Daromadning choraklik o'sishi (QoQ) Soleno Therapeutics Inc SLNO|Choraklik daromad o'sishi Amicus Therapeutics Inc FOLD|89bio Corp - Choraklik daromad o'sishi|O'tgan chorakka nisbatan daromad o'zgarishi Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Daromadning choraklik o'sishi (QoQ)|Choraklik sotuv o'sishi MiMedx Group, Inc.|Daromadning choraklik o'sishi (QoQ) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Choraklik sotuv ortish sur'ati|Choraklik daromad o'sishi MBX|Choraklik sotuv o'sishi Altimmune, Inc. ALT|Choraklik daromad o'sishi AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Choraklik daromad o'sish sur'ati|BIOA: Choraklik sotuv o'sishi|Choraklik daromad ortishi BMEA (Biomea Fusion)|QNCX (quincetx.com) - Choraklik sotuv o'sishi|Fractyl - Choraklik daromad ortishi|VTVT (vTv Therapeutics Inc) - Choraklik daromad o'sishi|Agape ATP - Daromadning choraklik dinamikasi|Choraklik sotuv o'sishi PLUR (Pluri Inc)|Choraklik sotuv ortish sur'ati Synlogic Inc.|Daromadning choraklik o'sishi (QoQ) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Choraklik daromad o'sish sur'ati|Spruce Biosciences Inc. - Choraklik daromad o'sishi|Choraklik sotuv ortish sur'ati Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Daromadning choraklik o'sishi (QoQ)|Lumos Pharma - Choraklik daromad ortishi|ONVO (Organovo Corp) - Choraklik daromad o'sishi|Radius Pharmaceuticals (RDUS) - Choraklik sotuv ortish sur'ati